title: Dasatinib-induced immunosuppression and recurrent respiratory tract infections.
authors.affiliation: a Division of Hematology-Oncology and Transplantation.
authors.forename: Faruk
authors.initials: F
authors.lastname: Obut
authors.affiliation: a Division of Hematology-Oncology and Transplantation.
authors.forename: Nicole
authors.initials: N
authors.lastname: Randall
authors.affiliation: b Division of Infectious Disease, Department of Medicine , University of Minnesota , Minneapolis , MN , USA.
authors.forename: Jo-Anne H
authors.initials: JA
authors.lastname: Young
authors.affiliation: c Division of Hematology and Hemostaseology, Department of Internal Medicine I , Medical University of Vienna , Vienna , Austria.
authors.forename: Peter
authors.initials: P
authors.lastname: Valent
authors.affiliation: a Division of Hematology-Oncology and Transplantation.
authors.forename: Celalettin
authors.initials: C
authors.lastname: Ustun
mesh_terms: D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male
chemical_list: D000068877:Imatinib Mesylate